Quarterly report · Q3
3154.TEDINET S100QPVK
Period2022-07-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amended by S100RJV8 (2023-08-14).
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥177.5bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥221.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥169.9bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥105.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥100.5bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥87.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥81.92 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.72 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.21 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.81 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥81.67 | 2022-07-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.11 | 2021-07-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥5.5bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥173.4bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥315m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥177.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥5.0bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥165.9bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥7.9bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-03-31 | ¥169.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-03-31 | ¥8.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)メディアスホールディングス㈱ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都千代田区有楽町一丁目２番２号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes when there is significant seasonal fluctuation in sales or operating expenses (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |